IP Library › Granted Patent US 10,450,551
Granted Patent B2
US 10,450,551 · App. 14/915,484 · Granted Oct 22, 2019

Enzyme composition and uses thereof

Inventors: Joseph Jump (Franklinton, NC); Nathaniel Kreel (Franklinton, NC); Jeremy Saunders (Franklinton, NC); Michael John Akerman (Franklinton, NC)
Assignee: NOVOZYMES A/S
C12N9/242C12N9/2417C12N9/2428C12N9/2434C12N9/2437C12N9/50C12N9/58C12P7/06C12P7/14C12P19/02C12P19/14C12Y302/01003C13K1/06C12Y302/01001C12Y302/01004Y02E50/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,450,551
App. No.
14/915,484
Granted
Oct 22, 2019
Kind
B2
Abstract

The invention relates to enzyme compositions comprising a glucoamylase, an alpha-amylase, and optionally a cellulolytic composition and/or a protease. The invention also relates to the use thereof in processes of producing sugars and/or fermentation products from starch-containing material by saccharifying and/or fermenting starch-containing material at a temperature below the initial gelatinization temperature.

Claims (24)

1. An enzyme composition comprising a glucoamylase and an alpha-amylase, and optionally a protease, wherein the glucoamylase comprises the amino acid sequence of SEQ ID NO: 17 or a variant thereof comprising an amino acid sequence having at least 85% sequence identity thereto, wherein the alpha-amylase comprises the amino acid sequence of SEQ ID NO: 13 or a variant thereof comprising an amino acid sequence having at least 85% sequence identity thereto.

2. The enzyme composition of claim 1 , further comprising a

a cellulolytic enzyme composition.

3. The enzyme composition of claim 2 , wherein the cellulolytic enzyme composition is derived from a strain of Trichoderma ; a strain of Humicola ; a strain of Chrysosporium ; or a strain of Penicillium.

4. The enzyme composition of claim 1 , wherein the enzyme composition comprises the Pycnoporus sanguineus glucoamylase shown in SEQ ID NO: 17 herein, and the alpha-amylase shown in SEQ ID NO: 13 having one or more of the following substitutions: G128D, D143N, or G128D+D143N.

5. The enzyme composition of claim 1 , wherein the alpha-amylase is the one shown in SEQ ID NO: 13 having one or more of the following substitutions: G128D, D143N, or G128D+D143N (using SEQ ID NO: 13 for numbering).

6. The enzyme composition of claim 1 , further comprising an enzyme selected from the group consisting of trehalase and pectinase.

7. A process of producing a fermentation product from starch containing material, comprising:

(i) saccharifying a starch-containing material at a temperature below the initial gelatinization temperature; and

(ii) fermenting using a fermentation organism;

wherein saccharification and/or fermentation is done in the presence of the enzyme composition of claim 1 .

8. The process of claim 7 , wherein the glucoamylase is the Pycnoporus sanguineus glucoamylase shown in SEQ ID NO: 17, and the alpha-amylase is the one shown in SEQ ID NO: 13 having any of the following substitutions: G128D, D143N, or G128D+D143N.

9. The process of claim 7 , further wherein saccharification and/or fermentation is done in the presence of a cellulolytic enzyme composition derived from a strain of Trichoderma, Humicola, Chrysosporium or Penicillium.

10. The process of claim 7 ,

wherein saccharification is done at a temperature below the initial gelatinization temperature, and

saccharification and/or fermentation is done in the presence of

a cellulolytic enzyme composition derived from a strain of Trichoderma reesei.

11. The process of claim 7 , wherein the ratio between glucoamylase and alpha-amylase is between 99:1 and 1:2 (mg EP glucoamylase: mg EP alpha-amylase).

12. The process of claim 1 , wherein the glucoamylase comprises an amino acid sequence having at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 17.

13. The process of claim 1 , wherein the glucoamylase comprises an amino acid sequence having at least 95% sequence identity to the amino acid sequence of SEQ ID NO: 17.

14. The process of claim 1 , wherein the glucoamylase comprises an amino acid sequence having at least 97% sequence identity to the amino acid sequence of SEQ ID NO: 17.

15. The process of claim 1 , wherein the alpha-amylase comprises an amino acid sequence having at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 13.

16. The process of claim 1 , wherein the alpha-amylase comprises an amino acid sequence having at least 95% sequence identity to the amino acid sequence of SEQ ID NO: 17.

17. The process of claim 1 , wherein the alpha-amylase comprises an amino acid sequence having at least 97% sequence identity to the amino acid sequence of SEQ ID NO: 17.

Continuity (4)
Provisional Application 61971936 · Mar 28, 2014
Provisional Application 61944933 · Feb 26, 2014
Provisional Application 61872180 · Aug 30, 2013
Related Publication 20160201041A1 · Jul 14, 2016